| Patents for A61P 35 - Antineoplastic agents (221,099) |
|---|
| 02/29/2000 | US6030797 Monoclonal antibodies against tumor-associated antigens, processes for the preparation thereof and the use thereof |
| 02/29/2000 | US6030793 Immunoassay for detecting a cell proliferation disorder using antibodies against proteins with a defined expression in prostate tissue; for diagnosis and monitoring the stage of malignancy |
| 02/29/2000 | US6030617 Use of growth differentiation factor-9 (GDF-9) to inhibit oocyte maturation |
| 02/29/2000 | US6030612 Antimicrobial uses of multifunctional enzyme |
| 02/29/2000 | CA2093928C Monoclonal antibodies for detection and treatment of cancer |
| 02/29/2000 | CA2003662C Glycosphingolipids with a group capable of coupling in the sphingoid portion, the preparation and use thereof |
| 02/29/2000 | CA2002648C 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine, uridine and guanosine derivatives |
| 02/24/2000 | WO2000009734A2 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | WO2000009733A1 Intracellular delivery vehicles |
| 02/24/2000 | WO2000009691A2 Bpc-1: a secreted brain specific protein expressed and secreted by prostate and bladder cancer cells |
| 02/24/2000 | WO2000009690A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | WO2000009675A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | WO2000009671A1 Process for purifying human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009665A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | WO2000009653A2 Method of inhibiting cathepsin k |
| 02/24/2000 | WO2000009616A1 Biologically active fraction of vegetable melanin, process for its production and its use |
| 02/24/2000 | WO2000009552A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | WO2000009549A2 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | WO2000009542A1 SERINE PROTEASE INHIBITORS COMPRISING α-KETO HETEROCYCLES |
| 02/24/2000 | WO2000009512A2 Bipyridine manganese complexes |
| 02/24/2000 | WO2000009510A1 Photocyclized rapamycins |
| 02/24/2000 | WO2000009507A1 Phenyl yanthine derivatives |
| 02/24/2000 | WO2000009503A1 Integrin receptor antagonists |
| 02/24/2000 | WO2000009495A1 Isoquinoline derivatives with angiogenesis inhibiting activity |
| 02/24/2000 | WO2000009492A1 Tace inhibitors |
| 02/24/2000 | WO2000009491A1 Calcilytic compounds |
| 02/24/2000 | WO2000009489A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | WO2000009485A1 Hydroxy pipecolate hydroxamic acid derivatives as mmp inhibitors |
| 02/24/2000 | WO2000009168A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | WO2000009160A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | WO2000009157A1 Protein delivery system using human papillomavirus virus-like particles |
| 02/24/2000 | WO2000009154A1 Bacterial superantigen vaccines |
| 02/24/2000 | WO2000009150A2 Cytokine and cytokine receptor, agonist, antagonist and/or antibody combination for therapeutic use |
| 02/24/2000 | WO2000009145A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | WO2000009143A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | WO2000009132A1 Calcilytic compounds |
| 02/24/2000 | WO2000009120A1 New use of taxoid derivatives |
| 02/24/2000 | WO2000009107A2 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | WO2000009097A2 Pharmaceutical composition with antitumor activity on the basis of carboplatin |
| 02/24/2000 | WO2000009086A2 Protected one-vial formulation for nucleic acid molecules, methods of making the same by in-line mixing, and related products and methods |
| 02/24/2000 | WO1999065947A3 Monoclonal antibodies directed against the g3bp protein, and uses |
| 02/24/2000 | WO1999062538A8 Alpha-keto oxadiazoles as serine protease inhibitors |
| 02/24/2000 | WO1999057133A3 Inhibitors of nf-kb activation |
| 02/24/2000 | WO1999049774A9 Methods for the diagnosis and treatment of lung cancer |
| 02/24/2000 | WO1999048868A3 Heterocyclic classes of compounds for the modulating tyrosine protein kinase |
| 02/24/2000 | WO1999045788A8 Food products having enhanced cocoa polyphenol content and processes for producing same |
| 02/24/2000 | WO1999045127A3 Enhanced prodrug activation |
| 02/24/2000 | DE19834610A1 New N-dipeptidyl O-acyl hydroxylamine derivatives useful as dipeptidyl peptidase I inhibitors, e.g. for treating cancer or immunological or metabolic disorders |
| 02/24/2000 | CA2341216A1 Bipyridine manganese complexes |
| 02/24/2000 | CA2340700A1 Photocyclized rapamycins |
| 02/24/2000 | CA2340682A1 Adenovirus formulations for gene therapy |
| 02/24/2000 | CA2340350A1 Phenyl yanthine derivatives |
| 02/24/2000 | CA2340341A1 Calcilytic compounds |
| 02/24/2000 | CA2340182A1 Tace inhibitors |
| 02/24/2000 | CA2340167A1 New carboxylic acid derivatives carrying keto side-chains, their production and their use as endothelin-receptor antagonists |
| 02/24/2000 | CA2340091A1 Combination therapies for b-cell lymphomas comprising administration of anti-cd20 antibody |
| 02/24/2000 | CA2340086A1 A method of transducing mammalian cells, and products related thereto |
| 02/24/2000 | CA2340085A1 Engineered antigen-presenting cells expressing an array of antigens and uses thereof |
| 02/24/2000 | CA2340068A1 Calcilytic compounds |
| 02/24/2000 | CA2339858A1 Treatment of tumors with oligonucleotides directed to insulin-like growth factor-i receptor |
| 02/24/2000 | CA2339748A1 Human stearoyl-coa desaturase-related compositions and methods for treating skin disorders |
| 02/24/2000 | CA2339405A1 Extracellular adhesive proteins, exadh1 and exadh2 |
| 02/24/2000 | CA2339328A1 Peripheral-type benzodiazepine receptor associated proteins, cloning, expression and methods of use |
| 02/24/2000 | CA2339304A1 Composition and method of using tumor cells |
| 02/24/2000 | CA2339300A1 Methods and compositions for use in spliceosome mediated rna trans-splicing |
| 02/24/2000 | CA2339047A1 Secreted proteins and polynucleotides encoding them |
| 02/24/2000 | CA2338878A1 Integrin receptor antagonists |
| 02/24/2000 | CA2338283A1 Multivalent avb3 and metastasis-associated receptor ligands |
| 02/24/2000 | CA2338184A1 Bacterial superantigen vaccines |
| 02/24/2000 | CA2336148A1 Sulfonamides of n-containing heterocyclic thioesters for vision and memory disorders |
| 02/24/2000 | CA2301201A1 Method of inhibiting cathepsin k |
| 02/23/2000 | EP0980866A2 Phenyl heterocycles as cyclooxygenase-2 inhibitors |
| 02/23/2000 | EP0980526A1 Inhibitors of nuclear protein/nuclear receptor interaction |
| 02/23/2000 | EP0980427A1 Use of ulip proteins in the diagnosis and therapy of cancer and paraneoplastic neurological syndromes |
| 02/23/2000 | EP0980424A2 Enzymatic nucleic acids: synthesis, selection and use |
| 02/23/2000 | EP0980384A1 Pregnane 3,2o diol mono- and di-sulphates |
| 02/23/2000 | EP0980383A1 Pharmaceutically acceptable salts of 3-hydroxy-estr-5(10)-en-17-one 3-sulphate active as estrogens |
| 02/23/2000 | EP0980382A1 Estrogenic 19-norandrost-17-one derivatives with an aromatic b-ring |
| 02/23/2000 | EP0980381A1 Pharmaceutically acceptable salts of 5.alpha.-pregn-16-en-3.beta.-ol-20-one 3-sulphate ester with progestin activity and useful in the treatment of cns disorders |
| 02/23/2000 | EP0980379A2 Chimeric oligonucleotides and the use thereof |
| 02/23/2000 | EP0980372A2 CYTOTOXIC COMPOUNDS: DERIVATIVES OF THE PYRIDO 2,3,4-$i(kl)] ACRIDINE RING SYSTEM |
| 02/23/2000 | EP0980354A2 Vitamin d 3? analogs with bis c-20 side chains |
| 02/23/2000 | EP0980349A1 Conjugated linolenic acid-based synthetic triglycerides |
| 02/23/2000 | EP0980251A1 Tissue factor for influencing blood vessel formation |
| 02/23/2000 | EP0980205A1 Method of treating malignancies |
| 02/23/2000 | EP0832063B1 Vitamin d derivatives with c-25 substituents, process for their preparation, intermediate products and their use in preparing medicaments |
| 02/23/2000 | CN1245536A Novel calpaines, production and use thereof |
| 02/23/2000 | CN1245501A Method and device for production of lyophilized hydrochloride -1 'beta', 10 'beta'-epoxy-13-dimethylamino-guaia -3(4)-6,12-olide |
| 02/23/2000 | CN1245486A Ketobenzamides as calpain inhibitors |
| 02/23/2000 | CN1245436A Pharmaceutical formulations for sustained drug delivery |
| 02/23/2000 | CN1245057A Reversing agent for multi-medicine resistance of tumor cells |
| 02/23/2000 | CN1049659C Corticotropin releasing factor antagonists |
| 02/23/2000 | CN1049653C Vitamin D3 analogs and pharmaceutical composition containing same |
| 02/23/2000 | CN1049651C Metalloproteinase inhibitors |
| 02/22/2000 | US6028223 An integrin antagonists treating bone disorder, periodontal disease, osteoporosis, humoral hypercalcemia of malignancy, paget's disease, tumor angiogenesis, diabetic retinopathy, arthritis, smooth muscle cell migration and restenosis |
| 02/22/2000 | US6028195 Piperazine derivatives and process for the preparation thereof |
| 02/22/2000 | US6028114 Use of aminothiolester derivatives in pharmaceutics |
| 02/22/2000 | US6028111 Compositions and use of benzamides and nicotinamides as anti-inflammatory agents |
| 02/22/2000 | US6028103 Triaryl methane compounds and analogues thereof useful for the treatment or prevention of sickle cell disease or diseases characterized by abnormal cell proliferation |
| 02/22/2000 | US6028090 Adhesion receptor antagonists III |